Table 1.
Baseline demographic and clinical characteristics of patients who had pulmonary tuberculoma or non-tuberculous pulmonary diseases
| Characteristic | Number of cases n = 135 | TB group n = 64 | Non-TB group n = 71 | P-value |
|---|---|---|---|---|
| Age (years) | 55.80 ± 14.07 | 53.80 ± 15.09 | 57.61 ± 12.92 | 0.117 |
| Gender (n, %) | ||||
| Male | 95 (70.37%) | 43 (67.19%) | 52 (73.24%) | 0.442 |
| Female | 40 (29.63%) | 21 (32.81%) | 19 (26.76%) | |
| BMI (kg/m2) | 21.35 ± 3.65 | 21.24 ± 3.73 | 21.81 ± 3.58 | 0.740 |
| Smoking (n, %) | 48 (35.56%) | 27 (42.19%) | 21 (29.58%) | 0.126 |
| Diadetes (n, %) | 27 (20.00%) | 17 (26.56%) | 10 (14.08%) | 0.070 |
| Symptoms (n, %) | ||||
| Cough | 63 (46.67%) | 29 (45.31%) | 34 (47.89%) | 0.765 |
| Chest pain | 12 (8.89%) | 6 (9.38%) | 6 (8.45%) | 0.851 |
| Hemoptysis | 15 (11.11%) | 4 (6.25%) | 11 (15.49%) | 0.088 |
| Fever | 12 (8.89%) | 5 (7.81%) | 7 (9.86%) | 0.677 |
| No symptoms | 44 (32.59%) | 21 (32.81%) | 23 (32.39%) | 0.959 |
| QFT (n, %) | ||||
| Positive | 93 (68.89%) | 58 (90.63%) | 35 (49.30%) | < 0.001 |
| Negative | 42 (31.11%) | 6 (9.38%) | 36 (50.70%) | |
| Lesion size (n, %) | ||||
| 1–2 cm | 53 (39.26%) | 22 (34.38%) | 31 (43.66%) | 0.270 |
| 2–3 cm | 82 (60.74%) | 42 (65.62%) | 40 (56.34%) | |
| Lesion location (n, %) | ||||
| Right upper lobe | 51 (37.77%) | 26 (40.63%) | 25 (35.21%) | 0.534 |
| Right middle lobe | 12 (8.89%) | 5 (7.81%) | 7 (9.86%) | |
| Right inferior lobe | 25 (18.53%) | 9 (14.06%) | 16 (22.54%) | |
| Left upper lobe | 31 (22.96%) | 14 (21.87%) | 17 (23.94%) | |
| Left inferior lobe | 16 (11.85%) | 10 (15.63%) | 6 (8.45%) | |
BMI body mass index; QFT QuantiFERON-TB Gold In-Tube test